Labajo, Lemuel Mar A.
HRN: 17-06-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/14/2024
03/21/2024
IV DRIP
2.25g
Q6h
Sepsis Sec To Typhoid Ileitis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes